Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Draper

Showing results (201-210 of 206) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 206 results.
IJTLD Open|October 15, 2025
Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countriesN Suryavanshi, H R Draper, G Dhumal, et al.
IJTLD Open|August 18, 2025
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countriesL Viljoen, H R Draper, N T Castillo-Carandang, et al.
Faraday Discussions|August 6, 2025
Design of gelling systems: general discussionDave J Adams, Vivien Andrieux, Simona Bianco, et al.
Faraday Discussions|August 6, 2025
Multicomponent systems: general discussionDave J Adams, Vivien Andrieux, Simona Bianco, et al.
Faraday Discussions|August 11, 2025
Characterising supramolecular gels: general discussionDave J Adams, Herdeline Ann M Ardoña, Simona Bianco, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 21

Showing results (201-210 of 206) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 206 results.
IJTLD Open|October 15, 2025
Acceptability of 100-mg moxifloxacin in children with rifampicin-resistant TB in three high-burden countriesN Suryavanshi, H R Draper, G Dhumal, et al.
IJTLD Open|August 18, 2025
Acceptability of a clofazimine tablet in children with rifampicin-resistant TB in three high-burden countriesL Viljoen, H R Draper, N T Castillo-Carandang, et al.
Faraday Discussions|August 6, 2025
Design of gelling systems: general discussionDave J Adams, Vivien Andrieux, Simona Bianco, et al.
Faraday Discussions|August 6, 2025
Multicomponent systems: general discussionDave J Adams, Vivien Andrieux, Simona Bianco, et al.
Faraday Discussions|August 11, 2025
Characterising supramolecular gels: general discussionDave J Adams, Herdeline Ann M Ardoña, Simona Bianco, et al.
The Lancet. Child & Adolescent Health|January 24, 2025
Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysisAnthony J Garcia-Prats, Maria Garcia-Cremades, Vivian Cox, et al.
Pageof 21